Publication: Diagnostic performance of reticulocyte hemoglobin equivalent in assessing the iron status
Issued Date
2020-01-01
Resource Type
ISSN
10982825
08878013
08878013
Other identifier(s)
2-s2.0-85079397361
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Clinical Laboratory Analysis. (2020)
Suggested Citation
Pawadee Chinudomwong, Aleeyas Binyasing, Rangsiri Trongsakul, Karan Paisooksantivatana Diagnostic performance of reticulocyte hemoglobin equivalent in assessing the iron status. Journal of Clinical Laboratory Analysis. (2020). doi:10.1002/jcla.23225 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/53601
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Diagnostic performance of reticulocyte hemoglobin equivalent in assessing the iron status
Other Contributor(s)
Abstract
© 2020 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals, Inc. Background: Measurement of reticulocyte hemoglobin equivalent (RET-He) is rapid, convenient, and cost-effective. Yet, researches on its performance in diagnosing iron deficiency with concurrent inflammation are limited. Hence, this study investigated RET-He value in various states, including inflammation, and evaluated its diagnostic performance in iron status assessment. Methods: Retrospectively, 953 clinical data and laboratory results—complete blood count, reticulocyte count, RET-He, and serum ferritin—were reviewed. Patients on iron therapy were excluded. Iron status was defined by serum ferritin as the reference method. RET-He among populations was investigated. Its diagnostic performance and optimal cutoff were determined by ROC analysis. Results: Three population groups were classified: healthy control, iron deficiency anemia (IDA), and non-ID anemia. Significantly, RET-He value in IDA was lower than that of healthy control, anemia of inflammation, and chronic kidney disease (P <.0001). Low RET-He was also observed in IDA with concomitant inflammation despite normal-to-high serum ferritin levels. No significant difference was observed between RET-He values in pure IDA and thalassemia (P =.57). ROC curve analysis revealed AUC of 0.876 (P <.0001) at cutoff 30 pg, by which IDA was discriminated with 74.2% sensitivity and 97.4% specificity. Applying cutoff ≤30 pg, IDA can be diagnosed with 96% sensitivity, 97.4% specificity, 80% PPV, and 99.6% NPV. Hence, RET-He >30 pg signifies a non-IDA state. Conclusion: In addition to convenience and cost-effectiveness, RET-He cutoff >30 pg can be potentially used to exclude IDA due to its excellent diagnostic sensitivity and specificity.